HALOZYME THERAPEUTICS, INC. Fair Value, Assets, Level 1 to Level 2 Transfers, Amount
HALOZYME THERAPEUTICS, INC. (HALO) had Fair Value, Assets, Level 1 to Level 2 Transfers, Amount of $0 as of 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount · last filed 2020-02-24
- 2019-12-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2018-12-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2018-09-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2018-06-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-24 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-24 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-21 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-08 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-09 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-20 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-28 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-02 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-08 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-07 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 |
| 2012-12-31 | $0.00 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |